ODI Pharma AB (XSAT:ODI) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ODI ODI Pharma AB XSAT:ODI
46 GF Score
Price kr2.10
GF Value kr9.62
Valuation Significantly Undervalued
View Full Analysis

What is ODI Pharma AB FFO per Share?

FFO per Share only applies to REITs.

XSAT:ODI
46GF Score
ODI Pharma AB XSAT:ODI
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?

Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued. The current stock price of kr2.10 is trading 78.2% below its estimated GF Value™ of kr9.62. GuruFocus considers ODI Pharma AB to be Significantly Undervalued.

Key valuation signals for XSAT:ODI:

  • FFO per Share:
  • GF Value™: kr9.62 vs. price of kr2.10 (78.2% below fair value)
  • GF Score™: 46/100

No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ODI Pharma AB Business Description

Address Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
46GF Score

Get the complete analysis for XSAT:ODI

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.10
Price
kr9.62
GF Value